# OnCo record nct05607004 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05607004/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05607004", "NCT05607004" ;
  schema:name "(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer"@en ;
  schema:alternateName "EVANGELINE"@en ;
  schema:description "A phase 2 trial of (Z)-endoxifen in HR-positive / HER2-negative breast cancer, run by Atossa Therapeutics, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05607004/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05607004> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-02-14" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:companies <https://onco.cc/companies/atossa-therapeutics/> .